QIAGEN expands presence in Thailand to serve life sciences

Food and Healthcare Press Releases Friday June 16, 2017 10:46
Bangkok--16 Jun--ABM
Opens Bangkok office and launches collaborations for malaria and cancer research

QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced its expansion in Thailand and opened an office in Bangkok to enhance relationships with life science researchers and healthcare providers in the growing market. QIAGEN also announced two new collaborations in Thailand: a molecular techniques center established with the faculty for tropical medicine at Mahidol University and a collaboration with Ramathibodi Hospital to study genomic insights from next-generation sequencing (NGS).

"We are pleased to expand our commitment to the people of Thailand, where we have built relationships with medical institutions and the government for more than 16 years. As we open our new Bangkok office, we are also introducing new collaborations with two of the country's leading medical institutions," said Mr. William Lin, Director of Commercial Operations for QIAGEN Thailand. "We look forward to providing Thai scientists and healthcare providers with innovative Sample to Insight solutions for molecular testing, including our NGS solutions, as we seek to make improvements in life possible."

The collaboration with Mahidol University has established the QIAGEN–TropMed Center for Molecular Techniques in conjunction with the Faculty of Tropical Medicine to support research using molecular biology techniques.

"We are happy to join with QIAGEN in creating the TropMed Center for Molecular Techniques to bring the benefits of genomic insights to research on malaria and other diseases. Our partnership will demonstrate the potential of academic-industry collaboration, as well as educate the younger generation in techniques of molecular biology," said Dr. Wang Nguitragool, Assistant Professor, Department of Molecular Tropical Medicine and Genetics, Faculty of Tropical Medicine of Mahidol University.

QIAGEN has joined with the Medical Genomic Center at Ramathibodi Hospital in Bangkok to help guide personalized healthcare treatment decisions using QIAGEN NGS solutions.

"QIAGEN NGS solutions, highly sensitive sequencing analyzes liquid biopsies or tissue samples to identify genetic mutations and enable doctors to select the best possible treatment. We expect this collaboration to have significant benefits for cancer patients," said Dr. Thanyanan Reungwetwattana, Assistant Professor, Division of Medical Oncology, Department of Medicine, Faculty of Medicine of Ramathibodi Hospital.

The expansion in Thailand supports QIAGEN's strategy of investing in emerging markets, where the use of advanced molecular technologies for medical care and research is growing rapidly. "The German-Thai Chamber of Commerce is proud to see another established German brand set root in Thailand. I am very happy to see that QIAGEN is expanding to Thailand because they bring their expertise to the local science community and contribute to the improvement of the life of the Thai people," said Dr. Roland Wein, Executive Director, German-Thai Chamber of Commerce. In 2016, QIAGEN sales in its top seven emerging markets grew 19% and contributed 16% of total net sales of $1.34 billion.


Latest Press Release

Merck Brings Customers Closer to Gene Therapy Product Commercialization

- Highlights position as leading contract manufacturing organization (CMO) for production of next-generation gene therapies Merck , a leading science and technology company, today announced that its Carlsbad, California-based manufacturing facility for...

Anpac Bio Surpasses 50,000 Case Study Milestone #Liquid Biopsy Pioneer# Serving Individual, Medical, Insurance Corporate Customers

Dr. Chris Yu, Chief Executive Officer of international life sciences corporation Anpac Bio-Medical Science Company , announced this week the company set a new, international record, processing and reporting over 50,000 cases worldwide of the company's...

Photo Release: The Royal Danish Embassy and Novo Nordisk join together to support the World Diabetes Day 2017 event, held on November 5, 2017

Recently, Mr.Uffe Wolffhechel, Ambassador of the Royal Danish Embassy, Thailand (right) together with Mr.Mihai Irimescu, General Manager of Novo Nordisk Pharma (Thailand) Co., Ltd (left) gave a special press interview on the 2017 World Diabetes Day event...

Pulsus Healthtech meetings and digital media coalition helping physicians# continued medical education

Pulsus Group is committed to working with medical societies and policymakers to improve the global healthcare education through its global medical and scientific conferences. With a legacy of 30 years of excellence in medical publishing and support from...

Avnet and MedIoTek to Transform Healthcare Delivery in India

Avnet (NYSE: AVT ), a leading global technology distributor, and MedIoTek Health Systems, announce a joint marketing agreement to promote MedIoTek's VinCense remote patient monitoring system. Under the agreement, Avnet will engage its broad network of...

Related Topics